The Clorox Company $CLX Shares Bought by Carlson Capital L.P.

Carlson Capital L.P. raised its position in shares of The Clorox Company (NYSE:CLX) by 122.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 18,050 shares of the company’s stock after buying an additional 9,950 shares during the period. Clorox comprises about 0.6% of Carlson Capital L.P.’s holdings, making the stock its 26th largest holding. Carlson Capital L.P.’s holdings in Clorox were worth $1,871,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. Caitlin John LLC raised its holdings in shares of Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after buying an additional 253 shares during the period. Darwin Wealth Management LLC purchased a new position in Clorox during the 2nd quarter valued at about $29,000. Vision Financial Markets LLC boosted its holdings in Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after acquiring an additional 200 shares during the period. Root Financial Partners LLC grew its position in Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after acquiring an additional 145 shares in the last quarter. Finally, SHP Wealth Management acquired a new position in Clorox in the 4th quarter valued at about $35,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Stock Down 1.1%

CLX stock opened at $95.66 on Friday. The company’s 50 day moving average price is $95.51 and its 200 day moving average price is $103.67. The firm has a market capitalization of $11.57 billion, a price-to-earnings ratio of 15.53 and a beta of 0.54. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $128.90. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter in the previous year, the firm earned $1.45 earnings per share. The firm’s quarterly revenue was up .1% on a year-over-year basis. On average, equities research analysts anticipate that The Clorox Company will post 5.52 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on CLX shares. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. The Goldman Sachs Group reiterated a “sell” rating and set a $83.00 target price on shares of Clorox in a report on Friday, May 1st. Wells Fargo & Company decreased their price target on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating for the company in a research report on Monday, May 18th. Citigroup dropped their price target on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a research note on Friday, May 1st. Finally, Barclays increased their price objective on Clorox from $85.00 to $86.00 and gave the company an “underweight” rating in a research note on Tuesday, July 21st. Twelve investment analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. According to MarketBeat, the company has an average rating of “Reduce” and a consensus price target of $101.00.

Insider Activity at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The shares were acquired at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.